LU90939I2 - 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates - Google Patents

3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates

Info

Publication number
LU90939I2
LU90939I2 LU90939C LU90939C LU90939I2 LU 90939 I2 LU90939 I2 LU 90939I2 LU 90939 C LU90939 C LU 90939C LU 90939 C LU90939 C LU 90939C LU 90939 I2 LU90939 I2 LU 90939I2
Authority
LU
Luxembourg
Prior art keywords
tetrahhydrocarbazole
methtylamino
frovatriptan
solvate
hydrate salts
Prior art date
Application number
LU90939C
Other languages
English (en)
Original Assignee
Vernalis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697363&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU90939(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vernalis Ltd filed Critical Vernalis Ltd
Publication of LU90939I2 publication Critical patent/LU90939I2/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU90939C 1991-06-26 2002-07-24 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates LU90939I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919113802A GB9113802D0 (en) 1991-06-26 1991-06-26 Medicaments
PCT/GB1992/001082 WO1993000086A1 (fr) 1991-06-26 1992-06-17 Utilisation de derives de tetrahydrocarbazone comme agonistes de recepteurs du type 5-ht¿1?

Publications (1)

Publication Number Publication Date
LU90939I2 true LU90939I2 (fr) 2002-09-24

Family

ID=10697363

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90939C LU90939I2 (fr) 1991-06-26 2002-07-24 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates

Country Status (35)

Country Link
US (2) US5464864A (fr)
EP (1) EP0591280B1 (fr)
JP (1) JP3261502B2 (fr)
KR (1) KR100251571B1 (fr)
CN (1) CN1034072C (fr)
AP (1) AP344A (fr)
AT (1) ATE170746T1 (fr)
BR (2) BR9206237A (fr)
CA (1) CA2113726C (fr)
CZ (3) CZ282327B6 (fr)
DE (2) DE69226953T2 (fr)
DK (1) DK0591280T3 (fr)
FI (1) FI103967B (fr)
GB (1) GB9113802D0 (fr)
HK (1) HK1014669A1 (fr)
HU (1) HU218907B (fr)
IE (1) IE922062A1 (fr)
IL (4) IL117104A (fr)
LU (1) LU90939I2 (fr)
MA (1) MA22563A1 (fr)
MX (1) MX9203444A (fr)
NL (1) NL300103I2 (fr)
NO (2) NO304774B1 (fr)
NZ (1) NZ243288A (fr)
PL (3) PL169392B1 (fr)
PT (1) PT100620B (fr)
RU (1) RU2137474C1 (fr)
SA (1) SA92130141B1 (fr)
SG (1) SG47877A1 (fr)
SI (1) SI9200125B (fr)
SK (3) SK280905B6 (fr)
TW (1) TW214544B (fr)
UA (1) UA41254C2 (fr)
WO (1) WO1993000086A1 (fr)
ZA (1) ZA924658B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
US5616603A (en) * 1995-05-26 1997-04-01 Smithkline Beecham Plc Enantiomers of carbazole derivatives as 5-HT1 -like agonists
GB9226566D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
GB9226530D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
US5618948A (en) * 1995-05-26 1997-04-08 Smithkline Beecham P.L.C. Process for preparing an enantiomer of a carbazole derivative
DE69610793T2 (de) * 1995-06-23 2001-05-03 Lilly Co Eli 6-Subsitituierte-1,2,3,4-tetrahydro-9H-Carbazole und 7-substituierte-1OH-Cyclohepta(7,6-B)-Indole
US5917054A (en) * 1995-07-18 1999-06-29 Smithkline Beecham P.L.C. Process for preparing enantiomers of carbazole derivatives as 5-HT1 -like agonists
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9723061D0 (en) * 1997-10-31 1998-01-07 Vanguard Medica Ltd Medicaments
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
US6066092A (en) * 1997-11-06 2000-05-23 Cady; Roger K. Preemptive prophylaxis of migraine device and method
GB9808069D0 (en) * 1998-04-16 1998-06-17 Vanguard Medica Ltd Novel processes
GB9817911D0 (en) * 1998-08-17 1998-10-14 Vanguard Medica Ltd New use
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
CN1662538A (zh) 2002-06-21 2005-08-31 苏文生命科学有限公司 可作为治疗剂的对血清素受体具有亲和力的芳烷基吲哚、其制备工艺及其含有该物质的药物组合物
MXPA04012832A (es) 2002-06-21 2005-05-27 Suven Life Sciences Ltd Arilsulfonil indoles novedosos que tienen afinidad por el receptor de la serotonina, utiles como agentes terapeuticos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
CA2509982C (fr) 2002-11-28 2011-11-08 Suven Life Sciences Limited Indoles n-arylsulfonyl-3-substitues presentant une affinite pour le recepteur de la serotonine, methode de preparation et composition pharmaceutique contenant ces indoles
AU2003285759B2 (en) 2002-11-28 2010-01-28 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
NZ540841A (en) 2002-12-18 2008-08-29 Suven Life Sciences Ltd Tetracyclic 3-substituted indoles having serotonin receptor affinity
NZ574705A (en) * 2006-08-07 2011-12-22 Actelion Pharmaceuticals Ltd (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
EP2813144A1 (fr) 2006-10-09 2014-12-17 Charleston Laboratories, Inc. Compositions analgésiques comprenant un antihistaminique
US8148377B2 (en) 2007-02-11 2012-04-03 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US20090069399A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched frovatriptan
WO2009089494A2 (fr) 2008-01-09 2009-07-16 Charleston Laboratories, Inc. Compositions pharmaceutiques
WO2010073253A1 (fr) * 2008-12-22 2010-07-01 Natco Pharma Limited Procédé de préparation de frovatripan optiquement actif
EP2451274B1 (fr) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Compositions pharmaceutiques
US10098674B2 (en) 2009-10-22 2018-10-16 Nuvasive, Inc. System and method for posterior cervical fusion
WO2011050140A1 (fr) 2009-10-22 2011-04-28 Blue Fury Consulting, L.L.C. Système et techniques de fusion cervicale postérieure
US9399053B2 (en) 2011-07-22 2016-07-26 The University Of Chicago Treatments for migraine and related disorders
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions
EP2816030A1 (fr) 2013-06-20 2014-12-24 Duke Chem, S. A. Procédés de préparation de frovatriptan et ses énantiomères
GB201312768D0 (en) 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure
WO2017152130A1 (fr) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Compositions pharmaceutiques
EP3766483A1 (fr) 2019-07-19 2021-01-20 BioPharma Synergies, S. L. Composition de poudre orodispersible comprenant un triptane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642816A (en) * 1967-08-10 1972-02-15 Sterling Drug Inc 3-acetamido-1 2 3 4-tetrahydrocarbazole
US3959309A (en) * 1968-01-24 1976-05-25 Sterling Drug Inc. 3-Amido-1,2,3,4-tetrahydrocarbazoles
US4062864A (en) * 1968-01-24 1977-12-13 Sterling Drug Inc. 3-Hydroxy carbazole derivatives
US3592824A (en) * 1970-03-12 1971-07-13 Miles Lab 3-substituted amino-1,2,3,4-tetrahydrocarbazoles
US4172834A (en) * 1971-08-16 1979-10-30 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
US4257952A (en) * 1977-06-06 1981-03-24 Sterling Drug Inc. 3-Amino-tetrahydrocarbazoles
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles
EP0115607A1 (fr) * 1983-01-04 1984-08-15 MERCK PATENT GmbH Dérivés de tétrahydrocarbazole

Also Published As

Publication number Publication date
ZA924658B (en) 1993-12-24
PT100620A (pt) 1993-09-30
WO1993000086A1 (fr) 1993-01-07
KR100251571B1 (ko) 2000-07-01
NL300103I2 (nl) 2003-02-03
FI103967B1 (fi) 1999-10-29
MX9203444A (es) 1993-12-01
FI935842A0 (fi) 1993-12-23
CA2113726C (fr) 2008-02-19
NL300103I1 (nl) 2002-12-02
IL117104A (en) 1997-09-30
SA92130141B1 (ar) 2005-12-18
SI9200125A (en) 1992-12-31
DE69226953D1 (de) 1998-10-15
NO934800D0 (no) 1993-12-23
CZ282061B6 (cs) 1997-05-14
IL117104A0 (en) 1996-06-18
TW214544B (fr) 1993-10-11
CZ150696A3 (en) 1997-06-11
CZ286193A3 (en) 1994-07-13
IL117105A0 (en) 1996-06-18
IE922062A1 (en) 1992-12-30
CA2113726A1 (fr) 1993-01-07
RU2137474C1 (ru) 1999-09-20
PL169410B1 (pl) 1996-07-31
DE10299042I2 (de) 2005-02-03
CN1069726A (zh) 1993-03-10
SK280905B6 (sk) 2000-09-12
HK1014669A1 (en) 1999-09-30
PL171034B1 (en) 1997-02-28
IL102322A (en) 1997-09-30
SI9200125B (en) 2001-12-31
NO2005011I1 (no) 2005-05-18
US5464864A (en) 1995-11-07
GB9113802D0 (en) 1991-08-14
CZ282327B6 (cs) 1997-06-11
FI103967B (fi) 1999-10-29
CN1034072C (zh) 1997-02-19
NO2005011I2 (no) 2008-02-11
IL117105A (en) 1998-01-04
DE69226953T2 (de) 1999-05-12
SG47877A1 (en) 1998-04-17
UA41254C2 (uk) 2001-09-17
NO934800L (no) 1993-12-23
PL169392B1 (pl) 1996-07-31
FI935842A (fi) 1993-12-23
IL102322A0 (en) 1993-01-14
AU652842B2 (en) 1994-09-08
EP0591280B1 (fr) 1998-09-09
CZ282083B6 (cs) 1997-05-14
MA22563A1 (fr) 1992-12-31
JPH06508827A (ja) 1994-10-06
NO304774B1 (no) 1999-02-15
US5637611A (en) 1997-06-10
SK280906B6 (sk) 2000-09-12
BR1100460A (pt) 2000-07-18
AP9200403A0 (en) 1992-07-31
AP344A (en) 1994-07-05
AU1977592A (en) 1993-01-25
HU218907B (hu) 2000-12-28
DE10299042I1 (de) 2003-02-20
SK280907B6 (sk) 2000-09-12
NZ243288A (en) 1994-09-27
JP3261502B2 (ja) 2002-03-04
HUT68961A (en) 1995-08-28
PT100620B (pt) 1999-01-29
DK0591280T3 (da) 1999-02-15
SK131993A3 (en) 1994-06-08
BR9206237A (pt) 1995-04-11
CZ150596A3 (en) 1997-05-14
EP0591280A1 (fr) 1994-04-13
ATE170746T1 (de) 1998-09-15

Similar Documents

Publication Publication Date Title
LU90939I2 (fr) 3-Methtylamino-6carboxamido-1,2,3,4-tetrahhydrocarbazole (frovatriptan) et ses sels solvates et hydrates
GB2256295B (en) Data storage and apparatus
EP0438961A3 (en) Hardware data string operation controller
GB2254469B (en) Data storage
EP0457563A3 (en) Slant rig cementing apparatus
DE69212210T2 (de) Sicherheitstrokar
GB9018928D0 (en) Laptop computer
EP0548928A3 (en) Portable computer
EP0520707A3 (en) Data storage apparatus
EP0465894A3 (en) Drilling device
GB9111730D0 (en) Portable drilling apparatus
NO921851L (no) "navlestreng"-frigjoeringsmekanisme
GB9101207D0 (en) Data security device
GB9209442D0 (en) Drilling device
EP0488366A3 (en) Data storage apparatus
GB2257194B (en) Computer security
GB9218156D0 (en) Improved drilling apparatus
GB2262443B (en) Wall marking device
EP0604030A3 (fr) Mémoire d'étiquettes pour antémémoire à post-mémorisation.
EP0480566A3 (en) Bit stuffing apparatus
CS434890A3 (en) Drilling device
HK1000677A1 (en) Data storage apparatus
GB9115880D0 (en) Gulf
ITLI910005A0 (it) Boa disinquinante ostrica
ITOR910001V0 (it) Chiave per apertura bilaterale.